We use cookies to analyze site usage and improve your experience. You can accept all, reject non-essential, or customize. See our Privacy Policy.
Reference sheet · Coagulation · CPC catalog code THBO-001
Full physicochemical data (sequence, molecular formula, molecular weight, CAS) is documented on the upstream certificate of analysis. Request the current lot COA from the supplier before use — values may vary between manufacturing runs.
Reference standards in the Coagulation class are typically shipped as lyophilized powder and stored desiccated at −20 °C protected from light. Once reconstituted in bacteriostatic water or the assay-appropriate buffer, aliquot and store at −80 °C to minimize freeze–thaw cycles. Confirm handling requirements against your institutional biosafety and radiation protocols before use.
LSKL, Inhibitor of Thrombospondin (TSP-1) sits within the Coagulation research class (CPC reference THBO-001). Coagulation peptides act either as chromogenic / fluorogenic substrates for thrombin, FXa, FVIIa, plasmin, and related proteases, or as inhibitors and receptor ligands (e.g. PAR-1/4 activators) that dissect specific cascade nodes. Investigators typically incorporate LSKL, Inhibitor of Thrombospondin (TSP-1) as a reference standard, tool ligand, or substrate in the assay contexts listed above. Read on kinetic plate readers at 405 nm (pNA) or fluorescence (AMC / MCA) endpoints.
LSKL, Inhibitor of Thrombospondin (TSP-1) (CPC catalog code THBO-001) is a synthetic coagulation cascade peptide / substrate in the coagulation category. It is provided as a lyophilized ~1 mg vial for in-vitro research use only.
Published and internal research programs use LSKL, Inhibitor of Thrombospondin (TSP-1) as a reference standard in coagulation workflows — for example, chromogenic protease-activity assays and par (protease-activated receptor) signaling studies. Human clinical evidence is not established.
No. LSKL, Inhibitor of Thrombospondin (TSP-1) is a research-grade reference peptide and is not approved by the FDA or any national regulator for human or veterinary therapeutic use. It is offered exclusively for in-vitro laboratory research and does not ship to the United States for consumer use.
In a coagulation workflow, LSKL, Inhibitor of Thrombospondin (TSP-1) is reconstituted in sterile buffer or DMSO (solubility-dependent) and applied in the researcher's chosen assay format. Read on kinetic plate readers at 405 nm (pNA) or fluorescence (AMC / MCA) endpoints.
Other reference standards in the same class — commonly cross-referenced during assay design and comparator selection.